Univariate and multivariate family-based association analysis of the IL-13 ARG130GLN polymorphism in the childhood asthma management program

Genetic Epidemiology

Volumn 23, Issue 4, 2002, Pages 335-348

  DeMeo, D L ^a,b   Lange, C ^c   Silverman, E K ^a,b   Senter, J M ^a,b   Drazen, J M ^a,b   Barth, M J ^a,b   Laird, N ^c   Weiss, Scott T ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Allergy; Asthma; Eosinophils; Family based; Genetic association studies; Interleukin 13; Single nucleotide polymorphism

Indexed keywords

ARGININE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; GLYCINE; IMMUNOGLOBULIN E; INTERLEUKIN 13; SALBUTAMOL; STEROID;

AIRWAY CONDUCTANCE; ALLERGY; ARTICLE; ASTHMA; BRONCHODILATATION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DNA DETERMINATION; DOUBLE BLIND PROCEDURE; EOSINOPHIL; FAMILIAL INCIDENCE; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHENOTYPE; QUANTITATIVE GENETICS; RANDOMIZED CONTROLLED TRIAL; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN TEST;

ALLERGENS; ASTHMA; CHI-SQUARE DISTRIBUTION; CHILD; DNA; EOSINOPHILS; FEMALE; GENOTYPE; HUMANS; IMMUNOGLOBULIN E; INTERLEUKIN-13; LINKAGE DISEQUILIBRIUM; MALE; NUCLEAR FAMILY; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX;

ANIMALIA; GENETTA;

EID: 0036857130     PISSN: 07410395     EISSN: None     Source Type: Journal    
DOI: 10.1002/gepi.10182     Document Type: Article

References (29)

1. Ahmed S, Ihara K, Sasaki Y, Nakao F, Nishima S, Fujino T, Hara T. 2000. Novel polymorphism in the coding region of the IL-13 receptor alpha′ gene: Association study with atopic asthma in the Japanese population. Exp Clin Immunogenet 17:18-22
2. Bochner BS, Klunk DA, Sterbinsky SA, Coffman RL, Schleimer RP. 1995. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J Immunol 154:799-803.
3. CAMP. 1999. The Childhood Asthma Management Program (CAMP): Design, rationale, and methods. Childhood Asthma Management Program Research Group. Controlled Clin Trials 20:91-120.
4. CAMP. 2000. Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group. N Engl J Med 343:1054-63.
5. de Vries JE. 1998. The role of IL-13 and its receptor in allergy and inflammatory responses. J Allergy Clin Immunol 102:165-9.
6. Graves PE, Kabesch M, Halonen M, Holberg CJ, Baldini M, Fritzsch C, Weiland SK, Erickson RP, von Mutius E, Martinez FD. 2000. A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children. J Allergy Clin Immunol 105:506-13.
7. Grunig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, Rennick DM, Sheppard D, Mohrs M, Donaldson DD, Lucksley RM, Curry DB. 1998. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282:2261-3.
8. Heinzmann A, Mao XQ, Akaiwa M, Kreomer RT, Gao PS, Ohshima K, Umeshita R, Abe Y, Braun S, Yamashita T, Roberts MH, Sugimoto R, Arima K, Arinuba Y, Yu B, Kruse S, Enumoto T, Dake Y, Kawai M, Shimazu S, Sasaki S, Adra CN, Kitaichi M, Inoue H, Yamanchi K, Tomichi N, Kurimoto F, Hamasaki N, Hopkin JN, Izuhara K, Shirakawa T, Deichmann KA. 2000. Genetic variants of IL-13 signalling and human asthma and atopy. Hum Mol Genet 9:549-59.
9. Howard TD, Whittaker PA, Zaiman AL, Koppelman GH, Xu J, Hanley MT, Meyers DA, et al. 2001. Identification and association of polymorphisms in the interleukin-13 gene with asthma and atopy in a Dutch population. Am J Respir Cell Mol Biol 25:377-84.
10. Howard TD, Koppelman GH, Xu J, Zheng SL, Postma DS, Meyers DA, Bleecker ER. 2002. Gene-gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthma. Am J Hum Genet 70:230-6.
11. Huang SK, Xiao HQ, Kleine-Tebbe J, Paciotti G, Marsh DG, Lichtenstein LM, Liu MC. 1995. IL-13 expression at the sites of allergen challenge in patients with asthma. J Immunol 155:2688-94.
12. Koning H, Neijens HJ, Baert MR, Oranje AP, Savelkoul HF. 1997. T cell subsets and cytokines in allergic and non-allergic children. I. Analysis of IL-4, IFN-gamma and IL-13 mRNA expression and protein production. Cytokine 9:416-26.
13. Laird NM, Horvath S, Xu X. 2000. Implementing a unified approach to family-based tests of association. Genet Epidemiol 19:36-42.
14. Lange C, Laird NM. 2002. On a general class of conditional tests for family-based association studies in genetics: The asymptotic distribution, the conditional power and optimality considerations. Genet Epidemiol (accepted-not in press).
15. Lange C, Silverman EK, Xu X, Weiss ST, Laird N. 2002b. A multivariate family-based association test using generalized estimating equations: FBAT-GEE. Biostatistics 1:1-15.
16. Li L, Xia Y, Nguyen A, Lai YH, Feng L, Mosmann TR, Lo D. 1999. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J Immunol 162:2477-87.
17. Liu X, Nickel R, Beyer K, Wahn U, Ehrlich E, Freidhoff LR, Bjorksten B, Beaty TH, Hwang SK. 2000. An IL13 coding region variant is associated with a high total serum IgE level and atopic dermatitis in the German multicenter atopy study (MAS-90). J Allergy Clin Immunol 106:167-70.
18. Marsh DG, Neely JD, Breazeale DR, Ghosh B, Freidhoff LR, Ehrlich-Kautzky E, Schou C, Krishnaswamy G, Beaty TH. 1994. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 264:1152-6.
19. Martinez FD, Solomon S, Holberg CJ, Graves PE, Baldini M, Erickson RP. 1998. Linkage of circulating eosinophils to markers on chromosome 5q. Am J Respir Crit Care Med 158:1739-44.
20. Meyers DA, Postma DS, Panhuysen CI, Xu J, Amelung PJ, Levitt RC, Bleecker ER. 1994. Evidence for a locus regulating total serum IgE levels mapping to chromosome 5. Genomics 23:464-70.
21. O'Connell JR, Weeks DE. 1998. PedCheck: A program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 63:259-66.
22. Palmer LJ, Daniels SE, Rye PJ, Gibson NA, Tay GK, Cookson WO, Goldblatt J, Burton PR, Le Souef PN. 1998. Linkage of chromosome 5q and 11q gene markers to asthma-associated quantitative traits in Australian children. Am J Respir Crit Care Med 158:1825-30.
23. Pawankar RU, Okuda M, Hasegawa S, Suzuki K, Yssel H, Okubo K, Okumura K, Ra C. 1995. Interleukin-13 expression in the nasal mucosa of perennial allergic rhinitis. Am J Respir Crit Care Med 152:2059-67.
24. Postma DS, Bleecker ER, Amelung PJ, Holroyd KJ, Xu J, Panhuysen CI, Meyers DA, Levitt RC. 1995. Genetic susceptibility to asthma - Bronchial hyperresponsiveness coinherited with a major gene for atopy. N Engl J Med 333:894-900.
25. Punnonen J, Cocks BG, de Vries JE. 1995. IL-4 induces germ-line IgE heavy chain gene transcription in human fetal pre-B cells. Evidence for differential expression of functional IL-4 and IL-13 receptors during B cell ontogeny. J Immunol 155:4248-54.
26. van der Pouw Kraan TC, van Veen A, Boeije LC, van Tuyl SA, de Groot ER, Stapel SO, Bakker A, Verweij CL, Aarden LA, van der Zee JS. 1999. An IL-13 promoter polymorphism associated with increased risk of allergic asthma. Genes Immun 1:61-5.
27. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, Donaldson DD. 1998. Interleukin-13: Central mediator of allergic asthma. Science 282:2258-61.
28. Ying S, Meng Q, Barata LT, Robinson DS, Durham SR, Kay AB. 1997. Associations between IL-13 and IL-4 (mRNA and protein), vascular cell adhesion molecule-1 expression, and the infiltration of eosinophils, macrophages, and T cells in allergen-induced late-phase cutaneous reactions in atopic subjects. J Immunol 158:5050-7.
29. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, Zhang Y, Elias JA. 1999. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production, J Clin Invest 103:779-88.